Ros-Lucas Albert, Correa-Fiz Florencia, Bosch-Camós Laia, Rodriguez Fernando, Alonso-Padilla Julio
Barcelona Institute for Global Health (ISGlobal), Hospital Clínic-University of Barcelona, 08036 Barcelona, Spain.
Animal Health Research Centre (CReSA, IRTA-UAB), IRTA, Bellaterra, 08193 Barcelona, Spain.
Pathogens. 2020 Dec 21;9(12):1078. doi: 10.3390/pathogens9121078.
African swine fever virus is the etiological agent of African swine fever, a transmissible severe hemorrhagic disease that affects pigs, causing massive economic losses. There is neither a treatment nor a vaccine available, and the only method to control its spread is by extensive culling of pigs. So far, classical vaccine development approaches have not yielded sufficiently good results in terms of concomitant safety and efficacy. Nowadays, thanks to advances in genomic and proteomic techniques, a reverse vaccinology strategy can be explored to design alternative vaccine formulations. In this study, ASFV protein sequences were analyzed using an in-house pipeline based on publicly available immunoinformatic tools to identify epitopes of interest for a prospective vaccine ensemble. These included experimentally validated sequences from the Immune Epitope Database, as well as de novo predicted sequences. Experimentally validated and predicted epitopes were prioritized following a series of criteria that included evolutionary conservation, presence in the virulent and currently circulating variant Georgia 2007/1, and lack of identity to either the pig proteome or putative proteins from pig gut microbiota. Following this strategy, 29 B-cell, 14 CD4 T-cell and 6 CD8 T-cell epitopes were selected, which represent a starting point to investigating the protective capacity of ASFV epitope-based vaccines.
非洲猪瘟病毒是非洲猪瘟的病原体,这是一种可传播的严重出血性疾病,会感染猪,造成巨大经济损失。目前既没有治疗方法也没有可用疫苗,控制其传播的唯一方法是大规模扑杀猪。到目前为止,传统的疫苗开发方法在安全性和有效性方面都没有取得足够好的结果。如今,由于基因组学和蛋白质组学技术的进步,可以探索反向疫苗学策略来设计替代疫苗配方。在本研究中,使用基于公开可用免疫信息工具的内部流程分析了非洲猪瘟病毒蛋白序列,以确定前瞻性疫苗组合中感兴趣的表位。这些包括来自免疫表位数据库的经实验验证的序列以及从头预测的序列。根据一系列标准对经实验验证和预测的表位进行排序,这些标准包括进化保守性、在强毒株和当前流行变体格鲁吉亚2007/1中的存在情况,以及与猪蛋白质组或猪肠道微生物群推定蛋白均无同源性。按照这一策略,选择了29个B细胞表位、14个CD4 T细胞表位和6个CD8 T细胞表位,这为研究基于非洲猪瘟病毒表位的疫苗的保护能力提供了一个起点。